Erdafitinib Currently Not FDA-Approved | Granted Breakthrough Designation Therapy

Erdafitinib Currently Not FDA-Approved | Granted Breakthrough Designation Therapy

User Photo
Annual-Meeting

2 years
165 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Erdafitinib Currently Not FDA-Approved | Granted Breakthrough Designation Therapy at Annual Meeting 2018
Up Next Autoplay